Panbela Therapeutics P/L
Qual é o P/L de Panbela Therapeutics?
O P/L de Panbela Therapeutics Inc. é 0.00
Qual é a definição de P/L?
A razão entre preço e lucro é a razão entre o preço das ações de uma empresa e o lucro por ação da empresa, calculado ao longo de doze meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/L de empresas na Setor Health Care em NASDAQ em comparação com Panbela Therapeutics
O que Panbela Therapeutics faz?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas com p/l semelhantes a Panbela Therapeutics
- Rurelec PLC tem P/L de 0.00
- Tomizone tem P/L de 0.00
- Nanogate AG tem P/L de 0.00
- SEL Manufacturing tem P/L de 0.00
- China Zhong Qi Hldgs tem P/L de 0.00
- MedSmart tem P/L de 0.00
- Panbela Therapeutics tem P/L de 0.00
- Epic tem P/L de 0.00
- 2574 tem P/L de 0.00
- GERRY WEBER International AG tem P/L de 0.00
- Houston Nat Res tem P/L de 0.00
- CTPartners Executive Search tem P/L de 0.00
- Crown ElectroKinetics tem P/L de 0.00